UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 55

Sortiert nach

Comparison of 111In-[DTPA0]Octreotide Versus Non Carrier Added 177Lu- [DOTA0,Tyr3]-Octreotate Efficacy in Patients With GEP-NET Treated Intra-arterially for Liver Metastases

Clinical nuclear medicine, 2016-03, Vol.41 (3), p.194-200

2016

Volltextzugriff (PDF)

Super-selective hepatic arterial infusions as established technique ('ARETAIEION' Protocol) of [177Lu]DOTA-TATE in inoperable neuroendocrine liver metastases of gastro-entero-pancreatic (GEP) tumors

The quarterly journal of nuclear medicine and molecular imaging, 2012-12, Vol.56 (6), p.551

2012

Volltextzugriff (PDF)

Introduction of a new semi-quantitative index with predictive implications in patients with painful osseous metastases after (186)Re-HEDP therapy

The quarterly journal of nuclear medicine and molecular imaging, 2011-02, Vol.55 (1), p.91

2011

Volltextzugriff (PDF)

Optimization of doses received by the hospital staff and the members of the family of patients undergoing 111In-DTPA-D-Phe1-Octreotide therapy

Radiation protection dosimetry, 2007, Vol.125 (1-4), p.403-406

2007

Volltextzugriff (PDF)

A case of hepatic flexure carcinoid with extended brain metastases

Journal of B.U. ON., 2011-10, Vol.16 (4), p.779

2011

Volltextzugriff (PDF)

Imaging and localization of pancreatic insulinomas

Clinical imaging, 2001-07, Vol.25 (4), p.275-283

2001

Volltextzugriff (PDF)

Palliative therapy using rhenium-186-HEDP in painful breast osseous metastases

Anticancer research, 1997-05, Vol.17 (3B), p.1767

1997

Volltextzugriff (PDF)

Rhenium-186-HEDP palliative treatment in disseminated bone metastases due to prostate cancer

Anticancer research, 1997-05, Vol.17 (3B), p.1699

1997

Volltextzugriff (PDF)

Management of metastatic bone pain with repeated doses of rhenium 186-HEDP in patients under therapy with zoledronic acid: a safe and additively effective practice

Cancer biotherapy & radiopharmaceuticals, 2009-10, Vol.24 (5), p.543

2009

Volltextzugriff (PDF)

Gastric uptake during Re-186 HEDP bone scintigraphy

Anticancer research, 1997-05, Vol.17 (3B), p.1779

1997

Volltextzugriff (PDF)

Renal cell carcinoma detection and systemic therapy with tumour-affine gallium-67 and with yttrium-90 citrate solutions

Anticancer research, 1997-05, Vol.17 (3B), p.1713

1997

Volltextzugriff (PDF)

Effects in the testes after SPECT myocardial perfusion with Tl-201 or Tc-99m hexaMIBI

Anticancer research, 1997-05, Vol.17 (3B), p.1841

1997

Volltextzugriff (PDF)

Advanced prostate cancer diagnosis and therapy with gallium-67 and yttrium-90, respectively

Anticancer research, 1997-05, Vol.17 (3B), p.1731

1997

Volltextzugriff (PDF)

Optimization of doses received by the hospital staff and the members of the family of patients undergoing super(111)In-DTPA-D-Phe super(1)-Octreotide therapy

Radiation protection dosimetry, 2007-07, Vol.125 (1-4), p.403-406

2007

Volltextzugriff (PDF)

Patient specific computer automated dosimetry calculations during therapy with 111In octreotide

2009 9th International Conference on Information Technology and Applications in Biomedicine, 2009, p.1-4

2009

Volltextzugriff (PDF)

Thalassemic osteoarthropathy treated by radiotherapy

Radiotherapy and oncology, 1992-06, Vol.24 (2), p.120-121

1992

Volltextzugriff (PDF)

Comparison of In-111 pentetreotide, Tc-99m (V)DMSA and I-123 mlBG scintimaging in neural crest tumors

Anticancer research, 1997-05, Vol.17 (3B), p.1589

1997

Volltextzugriff (PDF)

Heterogeneity of Duodenal Ulcer as Suggested by Differences in Gastrin Response to a Protein Meal

Annals of the New York Academy of Sciences, 1986-05, Vol.463 (1), p.334-336

1986

Volltextzugriff (PDF)

99mTc-Norfloxacin: One step kit formulation of the potential infection imaging agent

Journal of labelled compounds & radiopharmaceuticals, 2001-05, Vol.44 (S1), p.S538-S540

2001

Volltextzugriff (PDF)

99m Tc‐Norfloxacin: One step kit formulation of the potential infection imaging agent

Journal of labelled compounds & radiopharmaceuticals, 2001-05, Vol.44 (S1)

2001

Volltextzugriff (PDF)

Protein meal and gastrin levels: a radioisotopic study in vitro

Nuclear medicine communications, 1986-02, Vol.7 (2), p.129-136

1986

Volltextzugriff (PDF)

99mTc-antigranulocyte bone marrow scintigraphy of breast and prostate skeletal metastases

Anticancer research, 1997-05, Vol.17 (3B), p.1615

1997

Volltextzugriff (PDF)

Isolated talus metastasis from breast carcinoma: a case report and review of the literature

Onkologie, 2005-03, Vol.28 (3), p.141-143

2005

Volltextzugriff (PDF)

Evaluation of the therapeutic response to In-111-DTPA octreotide-based targeted therapy in liver metastatic neuroendocrine tumors according to CT/MRI/US findings

Cancer biotherapy & radiopharmaceuticals, 2005-04, Vol.20 (2), p.215-217

2005

Volltextzugriff (PDF)

Dosimetry in nuclear myocardial studies: Patient dosimetry and staff exposure

Nuclear medicine communications, 1999-07, Vol.20 (7), p.681

1999

Volltextzugriff (PDF)

1 – 25 von 55

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(38)
Mit Volltextzugriff
(30)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

Male
(26)
Humans
(24)
Science & Technology
(19)
Life Sciences & Biomedicine
(18)
Female
(16)
Middle Aged
(16)
Adult
(14)
Aged
(12)
Oncology
(12)
Radionuclide Imaging
(11)
Bone Neoplasms - Secondary
(10)
Bone Neoplasms - Diagnostic Imaging
(7)
Bone Neoplasms - Radiotherapy
(7)
Prostatic Neoplasms - Pathology
(7)
Radiology, Nuclear Medicine & Medical Imaging
(7)
Aged, 80 And Over
(6)
Animals
(6)
Magnetic Resonance Imaging
(6)
Mice
(6)
Prostatic Neoplasms - Radiotherapy
(6)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Comparison of 111In-[DTPA0]Octreotide Versus Non Carrier Added 177Lu- [DOTA0,Tyr3]-Octreotate Efficacy in Patients With GEP-NET Treated Intra-arterially for Liver Metastases

Super-selective hepatic arterial infusions as established technique ('ARETAIEION' Protocol) of [177Lu]DOTA-TATE in inoperable neuroendocrine liver metastases of gastro-entero-pancreatic (GEP) tumors

Introduction of a new semi-quantitative index with predictive implications in patients with painful osseous metastases after (186)Re-HEDP therapy

Optimization of doses received by the hospital staff and the members of the family of patients undergoing 111In-DTPA-D-Phe1-Octreotide therapy

A case of hepatic flexure carcinoid with extended brain metastases

Imaging and localization of pancreatic insulinomas

Palliative therapy using rhenium-186-HEDP in painful breast osseous metastases

Rhenium-186-HEDP palliative treatment in disseminated bone metastases due to prostate cancer

Management of metastatic bone pain with repeated doses of rhenium 186-HEDP in patients under therapy with zoledronic acid: a safe and additively effective practice

Gastric uptake during Re-186 HEDP bone scintigraphy

Renal cell carcinoma detection and systemic therapy with tumour-affine gallium-67 and with yttrium-90 citrate solutions

Effects in the testes after SPECT myocardial perfusion with Tl-201 or Tc-99m hexaMIBI

Advanced prostate cancer diagnosis and therapy with gallium-67 and yttrium-90, respectively

Optimization of doses received by the hospital staff and the members of the family of patients undergoing super(111)In-DTPA-D-Phe super(1)-Octreotide therapy

Patient specific computer automated dosimetry calculations during therapy with 111In octreotide

Thalassemic osteoarthropathy treated by radiotherapy

Comparison of In-111 pentetreotide, Tc-99m (V)DMSA and I-123 mlBG scintimaging in neural crest tumors

Heterogeneity of Duodenal Ulcer as Suggested by Differences in Gastrin Response to a Protein Meal

99mTc-Norfloxacin: One step kit formulation of the potential infection imaging agent

99m Tc‐Norfloxacin: One step kit formulation of the potential infection imaging agent

Protein meal and gastrin levels: a radioisotopic study in vitro

99mTc-antigranulocyte bone marrow scintigraphy of breast and prostate skeletal metastases

Isolated talus metastasis from breast carcinoma: a case report and review of the literature

Evaluation of the therapeutic response to In-111-DTPA octreotide-based targeted therapy in liver metastatic neuroendocrine tumors according to CT/MRI/US findings

Dosimetry in nuclear myocardial studies: Patient dosimetry and staff exposure

Suchergebnisse filtern